Medicaid Prior Authorization Policies – State Survey Findings
Table of Contents
Medicaid Managed Care Organizations (MCOs) play a crucial role in delivering healthcare to millions, but navigating denials and appeals can be a significant challenge for enrollees. Understanding the appeals process, and the availability of external review options, is vital for ensuring access to necessary care.This article explores the current landscape of Medicaid appeals, highlighting recent findings and the growing importance of independent oversight.
Understanding the Medicaid Appeals process
When an MCO denies a service request, enrollees have the right to appeal. The initial step involves appealing directly to the MCO for reconsideration. However, a recent report from the Medicaid and CHIP Payment and Access Commission (MACPAC) suggests enrollees may lack confidence in data provided by MCOs, or hesitate to seek help from the very entity that issued the denial. This hesitation underscores the need for accessible, unbiased support throughout the appeals journey.
Fortunately, external entities like state ombudsperson offices and legal aid societies can provide crucial assistance. While states are increasingly recognizing this need, a 2024 KFF/HMA state survey revealed inconsistencies in how states were asked about funding for these external support systems, making it tough to determine the exact number providing such resources.
The Role of Independent External Medical Review
If an MCO upholds its initial denial, states have the option to offer an independent external medical review. This process involves a clinical review of the MCO’s decision by a third party unaffiliated with the state or the MCO itself. Crucially, this review must be offered at no cost to the enrollee and cannot interrupt ongoing benefits or discourage a state fair hearing – a further level of appeal involving an administrative law judge.
The availability of external review is a key differentiator between Medicaid and Medicare Advantage. In Medicare Advantage, cases are automatically sent for independent review upon denial by the plan. A 2019 report from the Office of Inspector General (OIG) suggests this automatic review contributes to a significantly higher appeal overturn rate in Medicare Advantage (82%) compared to Medicaid mcos (36%).
Increasing Access to External Review in Medicaid
Recognizing the potential benefits of independent review, more states are begining to offer this option to their Medicaid enrollees.
As of July 1, 2024, at least one-third of responding MCO states (15 of 39) provide access to an independent external medical review process to review an MCO’s decision to uphold a denial. This represents a positive trend, showing a slight increase compared to OIG’s 2019 findings.
Why Independent Review Matters
The disparity in appeal overturn rates between Medicare Advantage and Medicaid MCOs highlights the importance of independent oversight. An unbiased review can ensure that medical decisions are based on sound clinical evidence, rather than financial considerations.
For Medicaid enrollees, access to external review can be particularly impactful. These individuals frequently enough face complex health needs and may have limited resources to navigate the appeals process on their own. Providing a fair and accessible appeals system, including independent review, is essential for upholding the principles of equitable healthcare access.